Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Timothy A. Horwedel"'
Autor:
Christina T. Doligalski, James N. Fleming, Laura M. Lourenco Jenkins, Jennifer Geyston, Timothy A. Horwedel, Barrett Crowther, Tricia Suarez
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:1144-1153
Autor:
Timothy A. Horwedel, Rowena Delos Santos, Jennifer C. Hagopian, Spenser E. January, Nicole M. Nesselhauf, Kristin Progar
Publikováno v:
Drugs & Aging. 38:397-406
Extended-release tacrolimus (LCP-Tac) prescribing information states that there is insufficient data in older adult patients from which to make recommendations on use in this population. This study sought to provide information on de novo use of LCP-
Autor:
Spenser E, January, Jennifer C, Hagopian, Nicole M, Nesselhauf, Kristin, Progar, Timothy A, Horwedel, Rowena Delos, Santos
Publikováno v:
Drugsaging. 38(5)
Extended-release tacrolimus (LCP-Tac) prescribing information states that there is insufficient data in older adult patients from which to make recommendations on use in this population. This study sought to provide information on de novo use of LCP-
Autor:
Andrew F. Malone, Felicia Bartlett, April A. Pottebaum, Spenser E. January, Timothy A. Horwedel
Publikováno v:
Clinical transplantationREFERENCES. 34(6)
Malignancy after solid organ transplant is a common occurrence that is associated with increased morbidity and mortality. Literature in the general diabetic population has identified possible antineoplastic properties of metformin. This retrospective
Autor:
Jason R. Wellen, Tarek Alhamad, Krista L. Lentine, Andrew F. Malone, Su-Hsin Chang, Daniel C. Brennan, Robert J. Stratta, Timothy A. Horwedel
Publikováno v:
Transplantation. 101:2757-2764
Successful pancreas transplantation requires surgical expertise and multidisciplinary medical management. The impact of transplant center volume on pancreas allograft survival remains unclear.We examined Organ Procurement and Transplantation Network
Autor:
Nicholas S. Britt, Ara Gharabagi, Daniel C. Brennan, April A. Pottebaum, Jennifer C. Hagopian, Carlos A. Q. Santos, Timothy A. Horwedel
Publikováno v:
Nephrology Dialysis Transplantation. 32:1758-1766
Background Urinary tract infections (UTIs) are common following kidney transplantation (KT); however, the influence of recurrent post-KT UTI (R-UTI) is not well-characterized. Methods We compared graft outcomes, patient outcomes and multidrug-resista
Autor:
Vikas R. Dharnidharka, Timothy A. Horwedel, Howard Chen, Jie Zheng, Nikhil Agarwal, Joseph G. Maliakkal, Kenneth B. Schechtman, Charles W. Goss, Dennis K. Fong, Daniel C. Brennan
Publikováno v:
Transplant International. 30:153-161
Ureteral stent (UrSt) placement has been shown to be a significant independent risk factor for BK viruria, viremia and BK virus nephropathy. We assessed if this observation could be validated at our high volume kidney transplant center that has had a
Autor:
Clarice E. Carthon, Timothy A. Horwedel, Felicia E. Bartlett, Jennifer C. Hagopian, Andrew F. Malone, Spenser E. January
Publikováno v:
Pharmacotherapy. 39(8)
Introduction One factor impacting tacrolimus interpatient variability is the presence of CYP3A5 polymorphisms. Low tacrolimus concentration-to-dose ratios (CDRs), or rapid metabolizers (RMs), have been associated with poor graft function outcomes and
Autor:
Daniel C. Brennan, Timothy A. Horwedel
Publikováno v:
Expert Opinion on Orphan Drugs. 4:1079-1086
Introduction: Tacrolimus has been used for prophylaxis of organ rejection since 1994, and has become a mainstay of immunosuppressive therapy. Tacrolimus XR tablets were released in the U.S. in 2015 and offer greater bioavailability and less variabili
Autor:
Teena Sam, Timothy A. Horwedel, Angela Q. Maldonado, Nicole A. Pilch, Christopher R. Ensor, Michael A. Shullo, A. Cochrane, Eric M. Tichy, Judith Jacobi, Lisa M. Potter
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 36:e195-e197
The American Society of Health-System Pharmacists’ Pharmacy Practice Model Initiative (PPMI) aims to develop and disseminate pharmacy practice models that optimize the use of pharmacists as direct care providers.1 In their commentary, Jacobi and co